INOVIO Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
/PRNewswire/ -- INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help protect people from infectious...
Jeff Richardson Michael John Sumner Eugene Kim Pharmaceuticals Inc Compensation Committee Chief Medical Officer
Source: prnewswire.com